SYRS - syros.com Book Valuation of Business

Public company logo of Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals (SYRS) develops innovative medical products based on DNA technologies, although external conflicts and sanctions create risks for raw material logistics and testing. This market trend, visualized in monetary terms with a value of -0.01, confirms the current price action. High R&D costs and patent protection for biomarkers create significant barriers to entry, while the trial stage temporarily limits the company's ability to exercise pricing power over future medications.

syros.com (SYRS) - Company Book Value from 07/04/2022 to 03/29/2025

Syros Pharmaceuticals, Inc. (SYRS) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Performance Chart Syros Pharmaceuticals, Inc|SYRS - Price Target Chart
- market capitalization data:
Market Capitalization Syros Pharmaceuticals Inc.|SYRS - Enterprise Value
- book capitalization data:
Equity per Share Syros Pharmaceuticals|SYRS - Company Book Value|Capitalization to Book Value Ratio syros.com|SYRS - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Syros Pharmaceuticals|SYRS - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Syros Pharmaceuticals Inc.|SYRS - Company Total Debt|Debts to Book Value Syros Pharmaceuticals Inc.|SYRS - Company Long-Term Debt|Company Short-Term Loans and Borrowings Syros Pharmaceuticals
Summary company analysis:Syros Pharmaceuticals, Inc - SYRS
Flagship merchandise of Syros

To minimize fundamental risks, investors evaluate the real value of net assets, calculated through the daily tracking of equity based on market closes. Amid workforce reductions and stagnating R&D processes at Syros Pharmaceuticals (SYRS), the current book capitalization reflects the liquidity burn rate and the resilience of residual capital in the face of high unit costs.

Competitors of Syros Pharmaceuticals

TEM: Accounting Value of Company|Qiagen N.V. - Company Book Value|ionispharma.com (IONS) - Book Valuation of Business|Book Capitalization Repligen (RGEN)|Accounting Capitalization RNA|Company Book Value CRISPR Therapeutics Corp CRSP|Accounting Capitalization GeneDx Corp (WGS)|Book Capitalization RARE (Ultragenyx Pharmaceutical)|beamtx.com - Book Capitalization|Company Book Value SRPT (Sarepta)|Twist Bioscience Inc (TWST) - Book Valuation of Business|Company Net Assets TXG|NTLA (Intellia Corp) - Total Stockholders' Equity|STOK - Company Book Value|Accounting Value of Company BLFS|Wave Life Sciences Ltd. - Company Book Value|Total Stockholders' Equity MAZE (Maze Therapeutics, Inc.)|Company Book Value SION|PRME - Book Valuation of Business|Company Net Assets Taysha Gene Therapies (TSHA)|QURE: Accounting Value of Company|Company Book Value MeiraGTx (MGTX)|REGENXBIO Inc (RGNX) - Net Asset Value|SLDB - Book Capitalization|Accounting Value of Company Ocugen Pharma|Book Capitalization PACB|Book Capitalization BNTC (benitec.com)|Company Book Value Design Therapeutics, Inc.|Rocket Pharma - Accounting Value of Company|FDMT: Company Book Value|LXEO - Company Net Assets|KRRO: Book Capitalization|editasmedicine.com (EDIT) - Book Capitalization|Book Capitalization SLN|Company Net Assets ProQR Therapeutics NV|Codexis, Inc. - Book Capitalization|Total Stockholders' Equity Sangamo BioSciences SGMO|Company Net Assets NAUT (Nautilus Bio)|MGX - Book Capitalization|Company Net Assets Precision BioSciences DTIL|GBIO - Total Net Assets|Boundless Bio, Inc - Book Capitalization|Exicure (XCUR) - Book Valuation of Business|Book Capitalization IMNN|Company Net Assets RXi Pharmaceuticals|Book Capitalization MBIO|Book Capitalization RNAZ (transcodetherapeutics.com)|Company Book Value Bionano Genomics BNGO|Applied DNA Corp - Company Book Value|Company Book Value BLUE (bluebird bio, Inc.)|IPA: Book Valuation of Business|Omega Therapeutics, Inc. - Company Book Value|Book Valuation of Business Singular Genomics Systems, Inc.|Company Net Assets RGLS (Regulus Therapeutics Inc)|Total Stockholders' Equity TBIO|TRACON Pharmaceuticals (TCON) - Company Book Value|Accounting Value of Company UBX (unitybiotechnology.com)